✦ LIBER ✦

Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands

✍ Scribed by Tjalke A Westra, Irina Stirbu-Wagner, Sara Dorsman…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN79 Cost Effectiveness of Human Papill

✍ Ross, K.D.; Cui, L.; Thomas, D.B. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Cost-effectiveness of prophylactic vacci

✍ R.M. Rogoza; T.A. Westra; N. Ferko; J.J. Tamminga; M.F. Drummond; T. Daemen; J.C 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 566 KB

The clinical benefit and cost-effectiven

✍ Johannes A. Bogaards; Veerle M.H. Coupé; Chris J.L.M. Meijer; Johannes Berkhof 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 337 KB

Cost-effectiveness analysis of Human Pap

✍ Maarten J. Postma 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Spotlight on Quadrivalent Human Papillom

✍ McCormack, Paul L.; Joura, Elmar A. 📂 Article 📅 2011 🏛 Springer International Publishing AG 🌐 English ⚖ 116 KB

Quadrivalent human papillomavirus vaccin

✍ Basil Donovan; Neil Franklin; Rebecca Guy; Andrew E Grulich; David G Regan; Hamm 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 196 KB